Skip to main content
. 2023 Dec 12;23:321. doi: 10.1186/s12935-023-03176-2

Fig. 4.

Fig. 4

Mechanism of action associated with a new STK33 inhibitor, Z29077885. A Cell cycle assay for anti-cancer efficacy of Z29077885 in MDA-MB-231 and A549 cell lines at 50 uM and 100 uM was measured by PI flow cytometry. B Cell cycle assay for the effect of BRD-8899 and ML-281 in MDA-MB-231 and A549 cell lines at 50 uM was measured by PI flow cytometry